Industries > Pharma > Global Norovirus Vaccines in Pipeline Forecast 2020-2030

Global Norovirus Vaccines in Pipeline Forecast 2020-2030

Takeda, Vaxart, Cocrystal Pharma, PanTheryx, Calici Therapeutics

PUBLISHED: 19 December 2019
PAGES: 98
PRODUCT CODE: PHA0643
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0643 Categories: , Tags: , , , , ,

The global norovirus vaccines market is estimated to grow at a CAGR of 7.6% during the forecast period. In 2022, North America is expected to hold a market share of 61% of the global norovirus vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The report provides clear detailed insight into the global norovirus vaccines in pipeline forecast. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Norovirus Vaccines in Pipeline forecast from 2020-2030

• Global Norovirus Vaccines in Pipeline forecast from 2020-2030 by Regional and National Market:
• North America: US, Canada
• EU5: Germany, France, UK, Italy, Spain
• APAC: Japan, China, India, Australia, ASEAN, Rest of APAC
• Central and South America: Brazil, Argentina, Rest of Central and South America
• Middle East and Africa: GCC, South Africa, North Africa, Rest of MEA

Global Norovirus Vaccines in Pipeline Forecast 2020-2030

• Profiles of the selected leading companies:
• Calici Therapeutics
• Cocrystal Pharma
• PanTheryx
• Takeda
• Vaxart

• List and discussion of candidate vaccines

• Key Questions Answered by this Report:
• What is the current size of the overall global norovirus vaccines market? How much will this market be worth from 2020 to 2030?
• What are the main drivers and restraints that will shape the overall norovirus vaccine market over the next ten years?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world vaccines? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2030?
• How will market shares of the leading national markets change by 2030, and which geographical region will lead the market in 2030?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are some of the most prominent norovirus vaccines currently in development?
• What are the main trends that will affect the world norovirus vaccines market between 2020 and 2030?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the demographic influences that will shape that industry over the next ten years?
• How will the global norovirus vaccines market evolve over the forecasted period, 2020 to 2030?

Buy our report today Global Norovirus Vaccines in Pipeline Forecast 2020-2030: Takeda, Vaxart, Cocrystal Pharma, PanTheryx, Calici Therapeutics.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Norovirus Vaccines in Pipeline Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Norovirus Vaccines in Pipeline Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category